首页|期刊导航|传统医学研究（英文版）|A comparative study on the changes of components dissolution ratio with different compatibility ratio of Panacis Quinquefolii Radix and Notoginseng Radix et Rhizoma and their prevention of Qi deficiency and blood stasis syndrome
A comparative study on the changes of components dissolution ratio with different compatibility ratio of Panacis Quinquefolii Radix and Notoginseng Radix et Rhizoma and their prevention of Qi deficiency and blood stasis syndrome
Song Xue Xi Mao Ding-Qiao Xu Rui-Jia Fu Ying Zhang Yu-Ping Tang
传统医学研究（英文版）2026，Vol.11Issue(1)：1-18,18.
传统医学研究（英文版）2026，Vol.11Issue(1)：1-18,18.DOI:10.53388/TMR20241212001
A comparative study on the changes of components dissolution ratio with different compatibility ratio of Panacis Quinquefolii Radix and Notoginseng Radix et Rhizoma and their prevention of Qi deficiency and blood stasis syndrome
A comparative study on the changes of components dissolution ratio with different compatibility ratio of Panacis Quinquefolii Radix and Notoginseng Radix et Rhizoma and their prevention of Qi deficiency and blood stasis syndrome
摘要
关键词
Panacis Quinquefolii Radix/Notoginseng Radix et Rhizoma/compatibility ratio/UPLC-Q/TOF-MS/UPLC-TQ-MS/MS/Qi deficiency and blood stasis syndromeKey words
Panacis Quinquefolii Radix/Notoginseng Radix et Rhizoma/compatibility ratio/UPLC-Q/TOF-MS/UPLC-TQ-MS/MS/Qi deficiency and blood stasis syndrome引用本文复制引用
Song Xue,Xi Mao,Ding-Qiao Xu,Rui-Jia Fu,Ying Zhang,Yu-Ping Tang..A comparative study on the changes of components dissolution ratio with different compatibility ratio of Panacis Quinquefolii Radix and Notoginseng Radix et Rhizoma and their prevention of Qi deficiency and blood stasis syndrome[J].传统医学研究（英文版）,2026,11(1):1-18,18.基金项目
This research was funded by the Entrusted service project of Shaanxi Administration of Traditional Chinese Medicine(ZYJXG-L23001),2023 Sanqin Talent Special Support Program Innovation and Entrepreneurship Team Project,and Sci-Tech Innovation Talent System Construction Program of Shaanxi University of Chinese Medicine(2023). （ZYJXG-L23001）
